EUVIMEDExplore EUVIMED
CrossrefInfo card

Evaluación económica del uso de pegfilgrastim frente a filgrastim en profilaxis primaria en pacientes con cáncer de mama con riesgo de padecer neutropenia febril en España

José Ignacio Mayordomo Cámara, Antonio López Pousa, Emmanuel Giménez García, Xavier Badia Llach, Núria Lara Surinyach, Francesc Sorio Vilela, Zhimei Liu, Raúl Arocho

PharmacoEconomics Spanish Research Articles · 2008

DOI: 10.1007/bf03320844 ↗
AbstractBibliographic details

Abstract

No abstract available.

Knowledge that fits your work.

From a free start through personal literature research to the complete Research Suite.

View plans →

Are all publisher full texts included?

No. Bibliographic records, abstracts and full texts are different content types. Full-text availability depends on the source, open access and your existing licences. An EUVIMED plan does not replace additional publisher rights.

View plans →